Genvion Corp 500 Camiel Sys Street Winnipeg Manitoba R2j 4k2 Canada

FDA Filings

This page includes the latest FDA filings for Genvion Corp 500 Camiel Sys Street Winnipeg Manitoba R2j 4k2 Canada. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
Lenalidomide Cipla USA Inc., Genvion Corporation 500 Camiel Sys Street, Winnipeg, Manitoba R2J 4K2, Canada, Cipla Ltd- Bommasandra	Prescription Medication	2023-03-10
lenalidomide Cipla USA Inc., Cipla Limited, Bangalore, Genvion Corporation 500 Camiel Sys Street, Winnipeg, Manitoba R2J 4K2, Canada	Prescription Medication	2023-03-07
lenalidomide Exelan Pharmaceuticals, Inc., Cipla USA Inc., Cipla Limited, Bangalore, Genvion Corporation 500 Camiel Sys Street, Winnipeg, Manitoba R2J 4K2, Canada	Prescription Medication	2022-10-15
lenalidomide Cipla USA Inc., Cipla Limited, Bangalore, Genvion Corporation 500 Camiel Sys Street, Winnipeg, Manitoba R2J 4K2, Canada	Prescription Medication	2022-09-13
lenalidomide Exelan Pharmaceuticals, Inc., Cipla USA Inc., Cipla Limited, Bangalore, Genvion Corporation 500 Camiel Sys Street, Winnipeg, Manitoba R2J 4K2, Canada	Prescription Medication	2022-09-13
efavirenz, emtricitabine and tenofovir disoproxil fumarate Exelan Pharmaceuticals, Inc., Genvion Corporation 500 Camiel Sys Street, Winnipeg, Manitoba R2J 4K2, Canada	Prescription Medication	2021-03-30